HABRI, NAVC initiative focuses on research supporting benefits of pet ownership, applications in veterinary practice.
The Human Animal Bond Research Institute (HABRI) and the North American Veterinary Community (NAVC) have launched a certification course for practicing veterinarians, veterinary nurses and practice managers: Human Animal Bond Certified.
Through a series of online modules created by experts in human-animal interaction science, veterinary professionals can learn about the health benefits of pet ownership and human-animal interaction and learn how best to use that knowledge in veterinary practice, according to a release from both associations.
Participants utilize an online interface at an individualized pace, focusing on aspects of veterinary practice ranging from better client dialogue to compliance to improved financial performance, says Tom Bohn, CEO of NAVC, in the release.
According to a recent HABRI survey of pet owners, veterinarians are a trusted resource for scientific information on the human health benefits of pets. When 2,000 pet owners were educated about the benefits of pet ownership:
Veterinarians, already viewed favorably by 97 percent of pet owners, are also viewed as important messengers for scientific information on the health benefits of pets, especially by millennial pet owners:
To assemble the course material, HABRI and the NAVC convened a group of highly qualified veterinarians, researchers and academics who have helped advance understanding of how pets improve human health. The AVMA was a key contributor, serving as a founding educational partner for the certification.
HABRI co-founders Zoetis and Petco are premier sponsors for the certification course, along with PetSmart Charities. For more information about the Human Animal Bond Certification, visit NAVC.com/HAB.
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans
Read More